Cargando…
Effect of metabolic genetic variants on long-term disease comorbidity in patients with type 2 diabetes
Underlying genetic determinants contribute to developing type 2 diabetes (T2D) future diseases. The present study aimed to identify which genetic variants are associated with the incident of the major T2D co-morbid disease. First, we conducted a discovery study by investigating the genetic associati...
Autores principales: | Abedian, Shifteh, Abbasi, Ali, de Boer, Anthonius, Stricker, Bruno H., Bakker, Stephan J. L., van der Harst, Pim, Sedaghat, Sanaz, Darvishian, Maryam, Ikram, M. Arfan, Navis, Gerjan, Dehghan, Abbas, Pen, Ido, Stolk, Ronald P., Snieder, Harold, Klungel, Olaf H., Souverein, Patrick, Alizadeh, Behrooz Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854581/ https://www.ncbi.nlm.nih.gov/pubmed/33531528 http://dx.doi.org/10.1038/s41598-021-82276-3 |
Ejemplares similares
-
Eosinophil Count Is a Common Factor for Complex Metabolic and Pulmonary Traits and Diseases: The LifeLines Cohort Study
por: Amini, Marzyeh, et al.
Publicado: (2016) -
Gastrointestinal toxicity among patients taking selective COX‐2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case–control study
por: Bakhriansyah, Mohammad, et al.
Publicado: (2017) -
Risk of myocardial infarction associated with non‐steroidal anti‐inflammatory drugs: Impact of additional confounding control for variables collected from self‐reported data
por: Bakhriansyah, Mohammad, et al.
Publicado: (2019) -
Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
por: Abbasi, Ali, et al.
Publicado: (2014) -
Patterns of antiplatelet drug use after a first myocardial infarction during a 10‐year period
por: Yasmina, Alfi, et al.
Publicado: (2016)